|
CENPA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.868400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.623000E-01 |
| Normal-vs-Stage2 |
1.331820E-01 |
| Normal-vs-Stage3 |
7.409200E-01 |
| Normal-vs-Stage4 |
7.028800E-01 |
| Stage1-vs-Stage2 |
6.979100E-03 |
| Stage1-vs-Stage3 |
8.618800E-01 |
| Stage1-vs-Stage4 |
9.521800E-01 |
| Stage2-vs-Stage3 |
3.010400E-02 |
| Stage2-vs-Stage4 |
3.705800E-02 |
| Stage3-vs-Stage4 |
9.304800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.264400E-01 |
| Normal-vs-AfricanAmerican |
2.268400E-01 |
| Normal-vs-Asian |
6.532200E-01 |
| Caucasian-vs-AfricanAmerican |
7.500300E-02 |
| Caucasian-vs-Asian |
7.857000E-01 |
| AfricanAmerican-vs-Asian |
2.038400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.321200E-01 |
| Normal-vs-Female |
5.771600E-01 |
| Male-vs-Female |
8.690400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.133800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.731570E-01 |
| Normal-vs-Age(61-80Yrs) |
6.898200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.797800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.827300E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.966800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.673570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.133800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.975800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.557190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.696400E-01 |
| Classical-VS-Follicular |
1.203570E-02 |
| Classical-VS-Other |
3.609000E-01 |
| Classical-VS-Normal |
7.666800E-01 |
| Tall-VS-Follicular |
1.167400E-01 |
| Tall-VS-Other |
6.244600E-01 |
| Tall-VS-Normal |
7.775400E-01 |
| Follicular-VS-Other |
6.988600E-01 |
| Follicular-VS-Normal |
1.870600E-01 |
| Other-VS-Normal |
4.261000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.712200E-01 |
| Normal-vs-N1 |
6.231600E-01 |
| N0-vs-N1 |
5.909400E-01 |
|
|
